Transcriptomics

Dataset Information

0

Transcriptomic analysis of DOXO-Resistant cells compared to parental DOXO-Sensitive mda-mb-436 cell line


ABSTRACT: The major obstacle in successfully treating triple negative breast cancer (TNBC) is resistance to cytotoxic chemotherapy, the mainstay of treatment in this disease. Previous pre-clinical models of chemoresistance in TNBC have suffered from a lack of clinical relevance. Using a single high dose chemotherapy treatment, we developed a novel MDA-MB-436 cell-based model of chemoresistance characterized by a unique and complex morphological phenotype, which consists of polyploid giant cancer cells (PGCCs) giving rise to neuron-like mononuclear daughter cells filled with smaller but functional mitochondria and numerous lipid droplets. This resistant phenotype is associated with metabolic reprogramming with a shift to a greater dependence on fatty acids and oxidative phosphorylation. We validated both the molecular and histologic features of this model in a clinical cohort of primary chemoresistant TNBCs and identified several metabolic vulnerabilities including a dependence on PLIN4, a perilipin coating the observed lipid droplets, expressed both in the TNBC resistant cells and clinical chemoresistant tumors treated with neoadjuvant doxorubicin-based chemotherapy. These findings thus reveal a novel mechanism of chemotherapy resistance that has therapeutic implications in the treatment of drug resistant cancer.

ORGANISM(S): Homo sapiens

PROVIDER: GSE138233 | GEO | 2019/11/30

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-01-05 | GSE252315 | GEO
2013-01-15 | E-GEOD-43502 | biostudies-arrayexpress
2024-02-24 | GSE256086 | GEO
2020-02-25 | E-MTAB-8787 | biostudies-arrayexpress
2022-09-20 | GSE206242 | GEO
2013-01-15 | GSE43502 | GEO
2024-10-02 | GSE247982 | GEO
2020-11-18 | GSE154243 | GEO
2022-05-31 | MTBLS4709 | MetaboLights
2011-12-20 | E-GEOD-28647 | biostudies-arrayexpress